A disturbing report from the American Cancer Society reveals that adults across the US are being diagnosed with colon and rectal cancers at younger ages, with a proportionate number of cases among adults under age 55 increasing from 11% in 1995 to 20% in 2019. Each month the U.S. Department of Health and Human Services selects National Health Observances (NHOs) that align with its priorities for improving health across the nation. In March, raising awareness about nutrition, colorectal cancer, and HIV/AIDS is the focus. People between ages 45 – 75 are urged to have regular screenings for colorectal cancer because the earlier it is diagnosed, the better the chances of survival. If the disease runs in the family, screening before age 45 is recommended. The American Cancer Society reports that 106,970 new cases of colon cancer and 46,050 new cases of rectal cancer will occur in 2023. Colorectal cancer is the third leading cause of cancer-related death in men and women, and when the numbers are combined, it’s the second most common cause of death in the United States. Treatment for colorectal cancer varies from patient to patient, but very often patients who undergo chemotherapy for colorectal cancer experience what’s known as “chemo brain.”
The goal of chemotherapy is to kill cancer cells, and most treatments target rapidly dividing cells, but as it eliminates fast-growing cancer cells, it also damages healthy cells. This leads to side effects including chemo brain, nausea, fatigue and/or a lowered immune system leading to infections. “Chemo brain” or “chemo fog” refers to a real disease. It’s highly frustrating to patients who suffer from thinking and memory problems, including disorganized behavior, confusion, memory loss, and trouble concentrating, retaining information, and making decisions. Chemo brain is especially challenging to individuals who previously operated at high cognitive levels. They often believe they will be able to overcome chemo brain by sheer will, when in fact, sadly, it’s not easily defeated. For some patients, the only option is to file a for long-term disability insurance claim.
Frankel & Newfield has represented many patients who have suffered cognitive changes following treatment for cancer when their long-term disability insurance claims were denied. There are a few tactics used by insurance companies for these claims:
The last thing someone suffering from chemo brain should be dealing with is battling a large disability insurance company with endless resources, including lawyers and doctors whose sole purpose is to deny claims. Our firm has fought every major disability insurance company and recovered millions of dollars of disability benefits for our clients.
Since 2004, our firm has focused on helping people who have had their long-term disability benefits denied. Partners Jason Newfield and Justin Frankel work directly with our clients, who benefit from their knowledge and experience. We have the experience, knowledge and tenacity needed to fight back when the disability insurance companies denies claims.
Jason Newfield is a founding partner of the disability insurance law firm Frankel & Newfield. He has spent the majority of his legal career advocating for the rights of disabled workers. He has lectured other professionals, worked on a Federal Advisory committee, and published many articles in the field of disability insurance claims and litigation.
Secrets the Disability Insurance Companies Don't Want You to Know!